Quick Answer
X4 Pharmaceuticals, Inc reported Total Assets of $290.46 million for fiscal year 2025.
X4 Pharmaceuticals, Inc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $290.46M | +98.3% |
| 2024 | $146.45M | -0.6% |
| 2023 | $147.26M | -5.4% |
| 2022 | $155.59M | +32.8% |
| 2021 | $117.18M | -4.6% |
| 2020 | $122.87M | -23.5% |
| 2019 | $160.70M | +1516.0% |
| 2018 | $9.94M | -87.8% |
| 2017 | $81.25M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $163.56M | -8.2% | +55.5% |
| June 30, 2025 | $105.17M | -50.1% | -19.1% |
| March 31, 2025 | $130.01M | +15.9% | -11.2% |
| December 31, 2024 | $146.45M | -0.6% | -17.8% |
| September 30, 2024 | $178.16M | +2.8% | -15.4% |
| June 30, 2024 | $210.61M | +21.5% | +87.7% |
| March 31, 2024 | $112.18M | -9.8% | -23.8% |
| December 31, 2023 | $147.26M | -5.4% | -15.0% |
- X4 Pharmaceuticals, Inc showed an increase of +98.3% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, X4 Pharmaceuticals, Inc’s total assets has grown by 257.5% (from $81.25 million to $290.46 million).
- The most recent figure is from X4 Pharmaceuticals, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: